Charles Schwab’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Charles Schwab’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-69,966	Closed	-$2.52M	–	3643
2022 Q4	$2.52M	Buy	69,966 +1,467	+2%	+$36.7K	﹤0.01%	2497
2022 Q3	$1.03M	Buy	68,499 +7,184	+12%	+$117K	﹤0.01%	2785
2022 Q2	$822K	Buy	61,315 +13,065	+27%	+$207K	﹤0.01%	2866
2022 Q1	$930K	Buy	48,250 +23,062	+92%	+$478K	﹤0.01%	2883
2021 Q4	$598K	Buy	25,188 +1,416	+6%	+$32.8K	﹤0.01%	3093
2021 Q3	$477K	Buy	+23,772	New	+$510K	﹤0.01%	3165

Charles Schwab's IMGO Position: Q1 2023 in Review

Charles Schwab sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 69,966 shares — an estimated $2.52M sold.

Charles Schwab first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $2.52M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Charles Schwab reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Charles Schwab sold 69,966 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $2.52M.
Charles Schwab first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Charles Schwab's Imago BioSciences, Inc. Common stock position peaked at $2.52M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.